Sumitomo Mitsui Trust Holdings, Inc. Natera, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 972,506 shares of NTRA stock, worth $176 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
972,506
Previous 935,768
3.93%
Holding current value
$176 Million
Previous $132 Million
24.16%
% of portfolio
0.11%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding NTRA
# of Institutions
704Shares Held
125MCall Options Held
590KPut Options Held
246K-
Vanguard Group Inc Valley Forge, PA12.7MShares$2.29 Billion0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$2.2 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.33 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.22 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.82MShares$871 Million3.66% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $17.5B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...